Kamada (KMDA) FCF Payout Ratio (QoQ) (2013 - 2026)
Kamada (KMDA) FCF Payout Ratio (QoQ) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.86 Bn | 42.90 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.19 Bn | 39.54 Bn | 2.15 Bn |
| 3 | Zoetis | 31.46 Bn | 29.79 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.57 Bn | 22.77 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.15 Bn | 19.49 Bn | 683.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.71 Bn | 11.18 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - |
| 10 | Kamada | 464.63 Mn | 435.16 Mn | 22.47 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -98.13% |
| Mar 31, 2026 | 902.58% |
| Dec 31, 2025 | -6.34% |
| Sep 30, 2025 | 547.27% |
| Jun 30, 2025 | -101.44% |
| Mar 31, 2025 | 10,377.37% |
| Dec 31, 2024 | -74.24% |
| Sep 30, 2024 | -11.20% |
| Jun 30, 2024 | -74.41% |
| Mar 31, 2024 | 2,241.42% |
| Dec 31, 2023 | -97.20% |
| Sep 30, 2023 | 159.47% |
| Jun 30, 2023 | 148.91% |
| Mar 31, 2023 | -144.95% |
| Dec 31, 2022 | 691.32% |
| Sep 30, 2022 | 48.53% |
| Jun 30, 2022 | -19.44% |
| Mar 31, 2022 | 103.35% |
| Dec 31, 2021 | -26.11% |
| Sep 30, 2021 | -147.41% |